Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
Sales | 11,423,310 | 10,074,800 | 10,788,210 | 10,648,050 | 9,748,200 |
Cost of Goods | 3,231,820 | 3,152,229 | 2,962,290 | 2,646,630 | 2,814,150 |
Gross Profit | 7,967,450 | 7,505,730 | 7,693,460 | 7,805,900 | 7,958,880 |
Operating Expenses | 5,131,540 | 5,562,789 | 4,872,070 | 5,061,620 | 4,973,050 |
Operating Income | 3,060,770 | 1,360,011 | 2,954,140 | 2,940,430 | 1,961,150 |
Interest Expense | 138,070 | 187,400 | 148,370 | 141,640 | 142,710 |
Other Income | -1,172,820 | -933,951 | -758,230 | -342,300 | 873,780 |
Pre-tax Income | 1,749,880 | 238,660 | 2,047,540 | 2,456,490 | 2,692,220 |
Income Tax | 367,740 | -116,950 | 469,630 | 617,630 | 678,940 |
Net Income Continuous | 3,186,602 | 595,360 | 2,219,439 | 2,219,049 | 3,203,600 |
Net Income | $3,186,602 | $595,360 | $2,219,439 | $2,219,049 | $3,203,600 |
EPS Basic Total Ops | 1.22 | 0.22 | 0.85 | 0.85 | 1.23 |
EPS Basic Continuous Ops | 1.22 | 0.23 | 0.85 | 0.85 | 1.23 |
EPS Diluted Total Ops | 1.22 | 0.22 | 0.85 | 0.85 | 1.23 |
EPS Diluted Continuous Ops | 1.22 | 0.23 | 0.85 | 0.85 | 1.23 |
EBITDA(a) | $3,060,770 | $1,360,011 | $2,954,140 | $2,940,430 | $1,961,150 |